Skip to main content

Yes SSIR: Letter to the Editor, Stanford Social Innovation Review


There were a number of good insights and promising strategies described in the Healthy Eating, Active Living special supplement of SSIR Summer 2019.  Yet the authors also admitted that child obesity and adult chronic diseases continue to grow.

One key weakness of the social determinants of health (SDOH) framework is that there are so many challenging “determinants,” that scarce resources for change can get spread and diluted.  So we end up with good SDOH change anecdotes—while actual state & national health statistics worsen.

To maximize impact, especially to reach the tipping point of actually reversing 40+ years of worsening health habits, we need to prioritize.  One highly promising “80/20” (and, yes, SDOH) strategy is through K-12 schools—literally with 20% of the US population, for 13 years, at just the right developmental stage to learn and change.  There are scalable, low cost, school-based strategies that dramatically increase fitness & activity, improve nutrition habits, develop social-emotional strengths, and reduce child obesity.  And school wellness policies and health advisory councils (SHACs) can help address many other social determinants.

But schools understandably resist “unfunded mandates” to make them scale these approaches.  The sustainable answer is to have those who benefit financially pay:  the health sector.  And to give schools incentives to be a proactive part of the solution.

Health plans & providers can reduce per capita costs, by $1000s during childhood and $10,000s to $100,000s in adulthood, by improving K-12 students’ health habits.  They can invest in schools to realize these savings, including using part of the school day.  But they need performance-based guarantees, that their investments will be utilized only for agreed evidence-based strategies, implemented with the necessary fidelity—then confirming with outcomes data that they are successfully achieving ROIs.  And school administrators need to see the value.

In Arizona, we are putting in place a self-reinforcing, self-funding combination of partners, policies, programs and payments to make this happen.  For example, we are making progress on:

-          - Reforming the state school accountability system, so that school superintendents can improve their schools’ state A-F letter grade, by improving physical & health education—as assessed with students’ fitness, activity & nutrition outcomes.  School leaders have clearly stated that this gives them a strong incentive to restore time, attention & resources to these neglected areas—which have been slashed by 2/3 in recent decades.

-          - Implementing a state recess law, which mandates 2 daily recesses K-5—thereby increasing physical activity for most 6-12 year olds by 50%—yet with local control of the details, and at no required cost to schools.

-          - Getting sustainable, performance-based funding from Medicaid plans and social impact investors, to scale a proven whole-school program with key PE & nutrition ed components. This is expected to save $30-50/student/year, at a cost of $10/student/year at-scale—by dramatically increasing activity and healthy eating, and thereby reducing child obesity, ADHD, depression, etc.

This is not an easy process.  But given the lack of other affordable, scalable, move-the-needle alternatives, this type of approach is worth serious consideration.

Comments

Popular posts from this blog

Is it a “Miracle Drug”?...if it Costs a Fortune and Creates Lifelong Dependency...&...Saggy Faces!?

[It’s been a while since our last blog post.  A lot has happened since– including some “miracles” ! So we’re going to do two posts in a row…] Normally we should all be happy about miracle drugs... shouldn't we ? Yes, there is lots of upside from taking semaglutide (Ozempic, Wegovy), tirzepatide (Montjaro)--and upcoming new, even-more-miraculous drugs TBD:  losing huge amounts of weight quickly, a much lower risk of diabetes–and probably less heart disease and other chronic conditions as well.  But what if the “miracle” requires:   $200-300/week, with a lifetime cost of hundreds of thousands of dollars…  a drug that you can never quit…because if you stop taking it, you gain back all the weight it helped you lose–not to mention the chronic diseases which the drugs kept at bay… and it leaves your face (and the rest of your skin?) sagging …    (plus, it’s so new at such high dosages– who knows what happens after years of use…? ) No doubt, in spit...

It’s Come To This for Many of Our Teens: Radical Surgery and/or a Lifetime of Pharmaceuticals

The American Academy of Pediatrics just came out in favor of powerful prescription drugs (which must be taken lifelong to avoid weight regain & chronic disease) for adolescents--and potentially for pre-teens (ages 8-11)--with moderate to severe obesity. Bari atric surgery (permanently reengineering kids’ gastrointestinal systems) should also be considered for adolescents with severe obesity .  (The Academy also recommends "nutrition support, physical activity, and behavioral therapy"--but as with so many other areas of US chronic disease management, we can see where default treatments are headed: drugs & surgical procedures.) Such radical treatment recommendations created the usual (and temporary and ineffectual) tsunami of news & social media shock and indignation. The decades-long performative reaction to the increasingly bad news on dangerous levels of early obesity–and now 1 in 3 teens with prediabetes, across ethnicities & income levels–is itself sicken...

Haven-Not: Silver-Bullet Health "Solution" Misfires

Can you have a better A-Team than this?   Amazon, Chase & Berkshire Hathaway joint venturing  via a new nonprofit, Haven, to finally solve our health care problems!   While I was hopeful when this joint venture was announced several years ago, I was also deeply skeptical.  Rather than addressing the root causes of health costs, such as inactivity and unhealthy nutrition, Haven tried  to "develop new ways to improve access to primary care, simplify insurance coverage and make prescription drugs more affordable"--including by throwing a lot of "big data" tech innovations at these issues. While this approach was pitched as a breakthrough, it was more of a Disease Management 2.0--focusing on more cost-efficient "care," rather than less chronic conditions to begin with.  The latter is the ultimate solution, but requires far more than blue-chip brands plus high-tech to resolve--and a lot more time.   2-3 years of effort just scratches the ...